Article Sidebar

PDF
Date Published: 23/09/2022
Abstract Views: 336
Views PDF: 191
DOI: https://doi.org/10.51298/vmj.v518i1.3339
Issue
Vol. 518 No. 1 (2022)
Section
Các bài báo
How to Cite
Minh Phúc, V. ., Thị Phi Nga, N. ., & Thúy Hường, P. . (2022). EVALUATION OF SOME CHARACTERISTICS OF SARCOPENIA DIAGNOSED BY THE FOMULAR OF ISHII ET AL IN DIABETES MELLITUS PATIENTS. Vietnam Medical Journal, 518(1). https://doi.org/10.51298/vmj.v518i1.3339

EVALUATION OF SOME CHARACTERISTICS OF SARCOPENIA DIAGNOSED BY THE FOMULAR OF ISHII ET AL IN DIABETES MELLITUS PATIENTS

Vũ Minh Phúc1,, Nguyễn Thị Phi Nga2, Phạm Thúy Hường3
1 National Hospital of Endocrinology
2 Vietnam Military Medical University
3 Military Hospital 103, Vietnam Military Medical University

Main Article Content

Abstract

Objective: Evaluation of some characteristics of sarcopenia diagnosed by formular of Ishii et al in diabetes mellitus (DM) patients. Methods: A cross-sectional study on 479 patients with type 2 diabetes mellitus admitted at the National hospital of endocrinology and the Military hospital 103 from January 2022 to May 2022. Results: The rate of sarcopenia increased 1,951 times in patients who were diagnosed with DM more than 10 years (CI 95%, OR: 1,259-3,024, p = 0,003; 1,728); and 1,782 times in patients with hypertension (CI 95%, OR: 1,106-2,698, p = 0,016; 7,872); and 7,872 times in patients with eGFR < 60ml/phút/1,73m2 (CI 95%, OR: 4,598-13,478, p < 0,001). It also decreased 0,481 time in patients taking metformin (CI 95%, OR: 0,311-0,745, p = 0,001). The points of formula of Ishii et al correlated negatively with eGFR, anthropometric index, educational status; and positively with test of stading up and go, duration of diabetes mellitus. Conclusion: The prevalence of sarcopenia increases with the duration of diabetes, HbA1c, hypertesion, decreases with eGFR, metformin treatment. The points of formula of Ishii et al correlated with another elements.

Article Details

Keywords

Sarcopenia, type 2 diabetes millitus, formula of Ishii et al

References

1. Chen, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Chou, M. Y., Iijima, K., … Arai, H., (2020), “Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment,” Journal of the American Medical Directors Association, 21(3), 300-307.e2.
2. Chen, L. K. Y., Liu, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Bahyah, K. S.,… Arai, H., (2014), “Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia,” Journal of the American Medical Directors Association, 15(2), 95–101.
3. Nguyễn Ngọc Tâm, Vũ Thị Thanh Huyền, & Phạm Thắng, (2021), “Nghiên cứu áp dụng một số phương pháp sàng lọc sarcopenia ở người bệnh cao tuổi,” Đại học Y Hà Nội.
4. Nguyễn Thị Thúy Hằng, (2021), “Nghiên cứu tình trạng mất cơ ở bệnh nhân đái tháo đường typ 2 và bước đầu đánh giá hiệu quả bằng luyện tập.,” Đại học Y Hà Nội.
5. Ishii, S., Tanaka, T., Shibasaki, K., Ouchi, Y., Kikutani, T., Higashiguchi, T., … Iijima, K., (2014), “Development of a simple screening test for sarcopenia in older adults,” Geriatrics and Gerontology International, 14(SUPPL.1), 93–101.
6. Beauchet, O., Fantino, B., Allali, G., Muir, S. W., & Annweiler, C., (2011), “Timed Up And Go Test And Risk Of Falls,” BMC Geriatrics, 15(10), 6–11.
7. Izzo, A., Massimino, E., Riccardi, G., & Pepa, G. Della, (2021), “A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.”.
8. Kusunoki, H., Tsuji, S., Kusukawa, T., Wada, Y., Tamaki, K., Nagai, K., … Shinmura, K., (2021), “Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia,” Clinical and Experimental Nephrology, 25(3), 231–239.